Membrane Protein Structural and Chemical Biology
Understanding the mechanisms of membrane enzymes, their mechanism of pathogenesis, and enabling their targeting by new therapeutics.
Lipid membranes are a chemical and physical barrier which separate the inside and outside of a cell and its organelles. Membrane proteins are therefore required for fundamental import nutrients, export waste, and transmit information within and between cells. Accordingly, these proteins are often mutated in disease and targeted by therapeutic drugs.
Our aim is to examine the biochemistry and determine atomic structures to describe the link between these proteins’ structure and function. To do so we work with scientific colleagues around the globe, developing tools to probe membrane proteins’ roles in human physiology. Through these results we will explain pathophysiology of toxins and mutations, validate these proteins as therapeutic targets, and develop new drugs to treat a variety of diseases.
Recently, our efforts have yielded the first detailed study of proline import by the transporter SIT1, and its complex with the SARS-CoV2 (COVID-19) receptor ACE2. We have also revealed the ping-pong reaction mechanism, and product-bound inhibited state of the ceramide synthase CerS6. Finally, in a collaborative study, our group revealed the substrate binding and transport triggers for SPNS2, which exports the immunoregulatory sphingosine-1-phosphate and the multiple sclerosis drug Fingolimod.
We have collaborations with academic and industrial partners worldwide. Our work is funded by several IMI consortia, pharma collaborators, the BBSRC and the MRC, the Royal Society, and the Macular Society.